Cargando…
Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
Galactose (Gal)-deficient IgA1 (Gd-IgA1) is involved in IgA nephropathy (IgAN) pathogenesis. To reflect racial differences in clinical characteristics, we assessed disease- and race-specific heterogeneity in the O-glycosylation of the IgA1 hinge region (HR). We determined serum Gd-IgA1 levels in Cau...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583103/ https://www.ncbi.nlm.nih.gov/pubmed/36277451 http://dx.doi.org/10.1016/j.isci.2022.105223 |
_version_ | 1784812995351674880 |
---|---|
author | Ohyama, Yukako Yamaguchi, Hisateru Ogata, Soshiro Chiurlia, Samantha Cox, Sharon N. Kouri, Nikoletta-Maria Stangou, Maria J. Nakajima, Kazuki Hayashi, Hiroki Inaguma, Daijo Hasegawa, Midori Yuzawa, Yukio Tsuboi, Naotake Renfrow, Matthew B. Novak, Jan Papagianni, Aikaterini A. Schena, Francesco P. Takahashi, Kazuo |
author_facet | Ohyama, Yukako Yamaguchi, Hisateru Ogata, Soshiro Chiurlia, Samantha Cox, Sharon N. Kouri, Nikoletta-Maria Stangou, Maria J. Nakajima, Kazuki Hayashi, Hiroki Inaguma, Daijo Hasegawa, Midori Yuzawa, Yukio Tsuboi, Naotake Renfrow, Matthew B. Novak, Jan Papagianni, Aikaterini A. Schena, Francesco P. Takahashi, Kazuo |
author_sort | Ohyama, Yukako |
collection | PubMed |
description | Galactose (Gal)-deficient IgA1 (Gd-IgA1) is involved in IgA nephropathy (IgAN) pathogenesis. To reflect racial differences in clinical characteristics, we assessed disease- and race-specific heterogeneity in the O-glycosylation of the IgA1 hinge region (HR). We determined serum Gd-IgA1 levels in Caucasians (healthy controls [HCs], n = 31; IgAN patients, n = 63) and Asians (HCs, n = 20; IgAN patients, n = 60) and analyzed profiles of serum IgA1 HR O-glycoforms. Elevated serum Gd-IgA1 levels and reduced number of Gal residues per HR were observed in Caucasians. Reduced number of N-acetylgalactosamine (GalNAc) residues per HR and elevated relative abundance of IgA1 with three HR O-glycans were common features in IgAN patients; these features were associated with elevated blood pressure and reduced renal function. We speculate that the mechanisms underlying the reduced GalNAc content in IgA1 HR may be relevant to IgAN pathogenesis. |
format | Online Article Text |
id | pubmed-9583103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-95831032022-10-21 Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy Ohyama, Yukako Yamaguchi, Hisateru Ogata, Soshiro Chiurlia, Samantha Cox, Sharon N. Kouri, Nikoletta-Maria Stangou, Maria J. Nakajima, Kazuki Hayashi, Hiroki Inaguma, Daijo Hasegawa, Midori Yuzawa, Yukio Tsuboi, Naotake Renfrow, Matthew B. Novak, Jan Papagianni, Aikaterini A. Schena, Francesco P. Takahashi, Kazuo iScience Article Galactose (Gal)-deficient IgA1 (Gd-IgA1) is involved in IgA nephropathy (IgAN) pathogenesis. To reflect racial differences in clinical characteristics, we assessed disease- and race-specific heterogeneity in the O-glycosylation of the IgA1 hinge region (HR). We determined serum Gd-IgA1 levels in Caucasians (healthy controls [HCs], n = 31; IgAN patients, n = 63) and Asians (HCs, n = 20; IgAN patients, n = 60) and analyzed profiles of serum IgA1 HR O-glycoforms. Elevated serum Gd-IgA1 levels and reduced number of Gal residues per HR were observed in Caucasians. Reduced number of N-acetylgalactosamine (GalNAc) residues per HR and elevated relative abundance of IgA1 with three HR O-glycans were common features in IgAN patients; these features were associated with elevated blood pressure and reduced renal function. We speculate that the mechanisms underlying the reduced GalNAc content in IgA1 HR may be relevant to IgAN pathogenesis. Elsevier 2022-09-27 /pmc/articles/PMC9583103/ /pubmed/36277451 http://dx.doi.org/10.1016/j.isci.2022.105223 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Ohyama, Yukako Yamaguchi, Hisateru Ogata, Soshiro Chiurlia, Samantha Cox, Sharon N. Kouri, Nikoletta-Maria Stangou, Maria J. Nakajima, Kazuki Hayashi, Hiroki Inaguma, Daijo Hasegawa, Midori Yuzawa, Yukio Tsuboi, Naotake Renfrow, Matthew B. Novak, Jan Papagianni, Aikaterini A. Schena, Francesco P. Takahashi, Kazuo Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy |
title | Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy |
title_full | Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy |
title_fullStr | Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy |
title_full_unstemmed | Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy |
title_short | Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy |
title_sort | racial heterogeneity of iga1 hinge-region o-glycoforms in patients with iga nephropathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583103/ https://www.ncbi.nlm.nih.gov/pubmed/36277451 http://dx.doi.org/10.1016/j.isci.2022.105223 |
work_keys_str_mv | AT ohyamayukako racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT yamaguchihisateru racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT ogatasoshiro racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT chiurliasamantha racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT coxsharonn racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT kourinikolettamaria racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT stangoumariaj racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT nakajimakazuki racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT hayashihiroki racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT inagumadaijo racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT hasegawamidori racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT yuzawayukio racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT tsuboinaotake racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT renfrowmatthewb racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT novakjan racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT papagianniaikaterinia racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT schenafrancescop racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy AT takahashikazuo racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy |